Laboratorios Farmaceuticos Rovi S.A. Logo

Laboratorios Farmaceuticos Rovi S.A.

Integrated pharma firm developing prescription drugs and offering contract manufacturing services.

ROVI | MC

Overview

Corporate Details

ISIN(s):
ES0157261019
LEI:
95980020140005936480
Country:
Spain
Address:
JULIAN CAMARILLO 35, 28037 Madrid
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Laboratorios Farmaceuticos Rovi S.A. is a specialized and fully integrated pharmaceutical company founded in 1946. The company's core activities encompass the research, development, manufacturing, and commercialization of a range of pharmaceutical products, with a focus on prescription and hospital-grade medicines. In addition to its proprietary product pipeline, ROVI also provides contract manufacturing services to third parties, offering a comprehensive suite of solutions including production, testing, packaging, and storage.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-18 00:00
Post-Annual General Meeting Information
La Sociedad informa sobre los acuerdos adoptados por su Junta General Ordinaria…
Spanish 152.8 KB
2025-05-08 07:56
Pre-Annual General Meeting Information
La Sociedad informa sobre el acuerdo de convocatoria de su Junta General Ordina…
Spanish 488.2 KB
2025-05-08 07:54
Regulatory News Service
ROVI informa sobre la concesión de una subvención en su favor para el desarroll…
Spanish 171.1 KB
2025-05-08 07:39
Investor Presentation
La Compañía hace pública la presentación relativa a los resultados financieros …
Spanish 957.7 KB
2025-05-08 07:35
Earnings Release
La Compañía hace público el comunicado de prensa relativo a los resultados fina…
Spanish 631.0 KB
2025-05-08 00:00
Pre-Annual General Meeting Information
La Sociedad informa sobre el acuerdo de convocatoria de su Junta General Ordina…
Spanish 488.2 KB
2025-04-04 10:27
Transaction in Own Shares
Operaciones sobre acciones propias efectuadas en el primer trimestre de 2025 en…
Portuguese 219.9 KB
2025-03-25 10:03
Investor Presentation
La Sociedad hace pública de nuevo la presentación en español relativa a la actu…
Spanish 2.3 MB
2025-03-25 08:00
Investor Presentation
La Sociedad hace pública la presentación relativa a la actualización de su estr…
Spanish 2.3 MB
2025-02-25 07:54
Report Publication Announcement
La Sociedad informa sobre los acuerdos adoptados por su Consejo de Administraci…
Spanish 85.6 KB
2025-02-25 07:49
Investor Presentation
La Sociedad hace pública la presentación de los resultados financieros del ejer…
Spanish 1.4 MB
2025-02-25 07:47
Earnings Release
La Sociedad hace público el comunicado de prensa relativo a los resultados fina…
Spanish 672.9 KB
2025-02-25 07:15
Remuneration Information
La Sociedad remite el Informe Anual sobre remuneraciones de los consejeros del …
Spanish 236.7 KB
2025-02-25 07:10
Governance Information
La sociedad remite el Informe Anual de Gobierno Corporativo del ejercicio 2024
Spanish 3.5 MB
2025-02-25 00:00
Annual / Quarterly Financial Statement
English 615.4 KB

Automate Your Workflow. Get a real-time feed of all Laboratorios Farmaceuticos Rovi S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Laboratorios Farmaceuticos Rovi S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden 2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
Abliva Logo
Develops clinical-stage medicines for rare primary mitochondrial diseases to restore cell function.
Sweden ABLI
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
Access Bio, Inc. Logo
Develops and manufactures rapid diagnostic tests for infectious diseases for global health.
United States of America 950130
Active Biotech Logo
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
Sweden ACTI

Talk to a Data Expert

Have a question? We'll get back to you promptly.